These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23214167)

  • 1. [Schizophrenia-like psychotic symptoms in a patient with confirmed Huntington's disease: a case report].
    Grabski B; Siwek M; Dudek D; Jaeschke R; Banaszkiewicz K
    Psychiatr Pol; 2012; 46(4):665-75. PubMed ID: 23214167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quetiapine in the treatment of behavioral disturbances in patients with Huntington's disease.
    Alpay M; Koroshetz WJ
    Psychosomatics; 2006; 47(1):70-2. PubMed ID: 16384811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of amisulpride and olanzapine in treatment-resistant schizophrenic psychoses.
    Zink M; Henn FA; Thome J
    Eur Psychiatry; 2004 Feb; 19(1):56-8. PubMed ID: 14969782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aripiprazole treatment for choreoathetoid and psychotic symptoms of Huntington's disease.
    Yavuz KF; Ulusoy S; Alnıak İ
    J Neuropsychiatry Clin Neurosci; 2013; 25(2):E31. PubMed ID: 23686053
    [No Abstract]   [Full Text] [Related]  

  • 5. [Amisulpride in Huntington's disease].
    Saft C; Andrich J; Kraus PH; Przuntek H
    Psychiatr Prax; 2005 Oct; 32(7):363-6. PubMed ID: 16220421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of psychotic and behavioral symptoms with clozapine, aripiprazole, and reboxetine in a patient with Huntington's disease.
    Edlinger M; Seppi K; Fleischhacker W; Hofer A
    Int Clin Psychopharmacol; 2013 Jul; 28(4):214-6. PubMed ID: 23652781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Psychiatric problems in a motor disorder: psychosis in Huntington's disease].
    van der Weijde E; Schadé A
    Tijdschr Psychiatr; 2015; 57(3):215-9. PubMed ID: 25856745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olanzapine in the treatment of agitation in hospitalized patients with schizophrenia and schizoaffective and schizofreniform disorders.
    Turczyński J; Bidzan L; Staszewska-Małys E
    Med Sci Monit; 2004 May; 10(5):PI74-80. PubMed ID: 15114282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aripiprazole in the treatment of olanzapine-resistant psychotic and motor symptoms of Huntington's disease.
    Oulis P; Mourikis I; Konstantakopoulos G; Papageorgiou SG; Kouzoupis AV
    J Neuropsychiatry Clin Neurosci; 2010; 22(3):352c.e4-352.e5. PubMed ID: 20686147
    [No Abstract]   [Full Text] [Related]  

  • 10. Sedation in acute and chronic agitation.
    Levy RH
    Pharmacotherapy; 1996; 16(6 Pt 2):152S-159S; discussion 166S-168S. PubMed ID: 8947999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid tranquilization of severely agitated patients with schizophrenia spectrum disorders: a naturalistic, rater-blinded, randomized, controlled study with oral haloperidol, risperidone, and olanzapine.
    Walther S; Moggi F; Horn H; Moskvitin K; Abderhalden C; Maier N; Strik W; Müller TJ
    J Clin Psychopharmacol; 2014 Feb; 34(1):124-8. PubMed ID: 24346752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined treatment with amisulpride in patients with schizophrenia discharged from a short-term hospitalization unit: a 1-year retrospective study.
    Molina JD; Lerma-Carrillo I; Leonor M; Pascual F; Blasco-Fontecilla H; González-Parra S; López-Muñoz F; Alamo C
    Clin Neuropharmacol; 2009; 32(1):10-5. PubMed ID: 18978498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of acute agitation in psychotic disorders.
    Mohr P; Pecenák J; Svestka J; Swingler D; Treuer T
    Neuro Endocrinol Lett; 2005 Aug; 26(4):327-35. PubMed ID: 16136016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychosis with Huntington's disease: role of antipsychotic medications.
    Ding J; Gadit AM
    BMJ Case Rep; 2014 Aug; 2014():. PubMed ID: 25139915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of severe agitation with olanzapine in 166 patients with schizophrenia, schizoaffective, or bipolar I disorder.
    Lambert M; Huber CG; Naber D; Schacht A; Wagner TT; Hundemer HP; Karow A; Schimmelmann BG
    Pharmacopsychiatry; 2008 Sep; 41(5):182-9. PubMed ID: 18763220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with amisulpride and olanzapine improve neuropsychological function in schizophrenia.
    Mortimer AM; Joyce E; Balasubramaniam K; Choudhary PC; Saleem PT;
    Hum Psychopharmacol; 2007 Oct; 22(7):445-54. PubMed ID: 17691076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment of negative symptoms and deficit states of chronic schizophrenia: olanzapine compared to amisulpride and placebo in a 6-month double-blind controlled clinical trial.
    Lecrubier Y; Quintin P; Bouhassira M; Perrin E; Lancrenon S
    Acta Psychiatr Scand; 2006 Nov; 114(5):319-27. PubMed ID: 17022791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's disease.
    De Deyn PP; Carrasco MM; Deberdt W; Jeandel C; Hay DP; Feldman PD; Young CA; Lehman DL; Breier A
    Int J Geriatr Psychiatry; 2004 Feb; 19(2):115-26. PubMed ID: 14758577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interpretations of hallucinations resolution by patient with chronic schizophrenia--case report].
    Murawiec S; Krzystoszek B
    Psychiatr Pol; 2009; 43(2):203-12. PubMed ID: 19697790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.